Navigation Links
Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences
Date:12/1/2011

WALTHAM, Mass., Dec. 1, 2011 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced today that multiple data presentations from phase 2 clinical trials with entinostat in combination and as a single agent will be made at upcoming scientific conferences. 

San Antonio Breast Cancer Symposium
Data from ENCORE 301, a multicenter, randomized, double-blind, placebo-controlled, phase 2 study of exemestane with and without entinostat in 130 postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer, will be presented in a poster discussion at the San Antonio Breast Cancer Symposium taking place December 6 to 10 in San Antonio, Texas.  Denise A. Yardley, MD, breast program leader, senior investigator at the Sarah Cannon Research Institute and principal investigator of the study, will present the data which will include an update on overall survival. 

Presentation Date/Time: Wednesday, December 7 from 5:00 PM - 7:00 PM
Poster Title: Entinostat, a Novel Histone Deacetylase Inhibitor, Added to Exemestane Improves PFS in Advanced Breast Cancer in a Randomized, Phase II, Double-Blind Study
Session: POSTER DISCUSSION I: Endocrine Resistance
Abstract Number: PD01-04
Location: Ballroom A

American Society of Hematology Annual Meeting and Exposition
Data from ENGAGE 501, a multicenter, phase 2 study entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, in patients with relapsed or refractory Hodgkin's lymphoma will be presented at the American Society of Hematology Annual Meeting and Exposition in San Diego on December 11 from 6:00 PM to 8:00
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
2. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
4. Pharmacyclics Reports Fiscal 2012 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 53rd American Society of Hematology Annual Meeting
5. Biogen-Idecs BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
6. Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth
7. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
8. DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex Assays on Calipers LabChip® Dx Platform
9. Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug
10. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
11. Phase 1 / 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma Published in the Journal of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
(Date:4/20/2015)... April 20, 2015 International Isotopes Inc. ... provide shareholders with the following update on its ... Historically, INIS has produced and ... several models of sealed sources for medical and ... radiation therapy, security examination, and radiography.  Due to ...
(Date:4/20/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ), ... therapies, today shared highlights of new data it ... (AACR) annual meeting. Halozyme also announced plans to ... study in pancreatic cancer, Study 202, next month ... of Clinical Oncology (ASCO). In an ...
Breaking Medicine Technology:Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... a settlement with Endo Pharmaceuticals, Inc. on outstanding patent ...  Endo filed its lawsuit on March 4, 2010, following ... with the U.S. Food and Drug Administration (FDA) for ...
... Oct. 7 Akorn, Inc. (Nasdaq: AKRX ) ... discuss third quarter 2010 results followed by a Q&A session. ... market opens.Subject: , Akorn Third Quarter 2010 Conference CallDate/Time: ... TimeDomestic Callers: , (888) 215-6895International Callers: , (913) ...
Cached Medicine Technology:Watson Reaches Settlement with Endo Over Opana® ER 2
(Date:4/20/2015)... A recent cross-sectional survey involving fibromyalgia ... top 10 most beneficial therapies for fibromyalgia, no drugs were ... therapies, only approved drugs were named. , “The biggest ... effect is only felt as long as the patient is ... , “On the other hand, aerobic exercise and other non-drug ...
(Date:4/20/2015)... Utah (PRWEB) April 20, 2015 Goodreads ... Employer-Provided Health Insurance: Why It’s Good for You and ... , Paul Zane Pilzer and Rick Lindquist have ... Health Insurance: Why It’s Good for You and Your ... nation’s employer health insurance woes - employer-funded individual health ...
(Date:4/20/2015)... York, New York (PRWEB) April 20, 2015 ... trade association representing the U.S. health insurance industry, ... a result of the recent controversy involving surgical ... a letter to U.S. Senator Robert Casey (D-PA) ... safety concerns surrounding uterine morcellation point to “serious ...
(Date:4/20/2015)... 2015 “ Verus ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... of purposes. , According to CNET, at least a ... 2013. It’s unfortunate that smartphones break so easily, but ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Northern ... Medicare & Medicaid Services introduced their new 5-star “Patient ... Consumer Assessment of Healthcare Providers and Systems) survey of ... patients about their experiences during a recent hospital stay. ... July 1, 2013 through June 30, 2014 can be ...
Breaking Medicine News(10 mins):Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3
... In times of economic,uncertainty, engaging employees becomes ... becomes much more challenging. Engaged employees feel a,strong ... and that, in,turn, translates into a more productive ... Programs and Activities that Work" delivers,insights into activities ...
... access comprehensive wireless provider ... ... Cross and Blue,Shield in Connecticut today announced the launch of the ... allow,Connecticut members to search for local, in-network doctors and hospitals,through any ...
... dedicated to influencing ... eating habits through education, PARKER, Colo., May 1 ... Council today unveiled Food for Thought from,Parents to Children, ... of three, Chef Gale Gand, and parents across,America. The ...
... inhale as deeply or exhale as fully as normal ... A study of women with a wide range of ... impact of asthma and also mask its severity in ... the changes in respiratory function that occur with asthmatic ...
... Sharing Progress and Promoting Future Strategies, HARRISBURG, Pa., ... Latino Affairs, today opened the PA Latino,Health Care Forum, ... held at the State Museum, is a follow up ... to address health disparities in,Pennsylvania. That summit was the ...
... WASHINGTON, May 1 The following media,advisory was ... Peter I. Buerhaus, PhD, RN, FAAN, Professor of ... Vanderbilt,University Medical Center, Nashville, TN; Karen Donelan, EdM, ... Health Policy,Boston, MA; Beth Ulrich, EdD, RN, FACHE, ...
Cached Medicine News:Health News:Complimentary Excerpt of Employee Engagement: Programs and Activities that Work Available from Best Practices 2Health News:Anthem Blue Cross and Blue Shield in Connecticut Introduces Industry's First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices 2Health News:Parents Can Educate Kids in the Kitchen With Cookbook from Chef Gale Gand and Wheat Foods Council 2Health News:Obesity May Worsen Impact of Asthma 2Health News:GACLA, Department of Health Hosts PA Latino Health Care Forum 2Health News:Will Nursing Shortage Cripple Future Health Care Plans? 2
... Superior Alternative to Bottled Water, The ... alternative for laboratories that currently use bottled ... to purchase, ship and store bottled water, ... - as contamination can be absorbed from ...
... Produces up to 12 L/min of Type ... On Demand, The Super-Q Plus System is ... water which has been pretreated by reverse ... consistently produce ultrapure water quality which exceeds ...
... Laboratory Needs, Synergy systems produce ultrapure water from ... to 1.2 L/min to meet the basic needs ... a dual-wavelength UV lamp (185 nm and 254 ... organic contaminants (< 5 ppb TOC when fed ...
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Built-in, motor-driven internal calibration ...
Medicine Products: